G37.2
Central pontine myelinolysis
Clinical Classification Guidelines
Medical Intelligence & Overview
Central pontine myelinolysis (CPM) is a rare neurological disorder characterized by damage to the myelin sheath in the pons, a part of the brainstem. This condition disrupts nerve signals in the area, leading to serious neurological symptoms. CPM is often associated with rapid shifts in body sodium levels, especially in the context of correcting severe hyponatremia. Recognizing and understanding CPM is essential for timely medical intervention and management.
Causes & Symptoms
Clinical Causes: Rapid correction of low blood sodium levels (hyponatremia) Severe malnutrition or liver disease Alcohol abuse Liver transplantation Certain medical procedures involving electrolyte correction
Key Symptoms: Difficulty speaking or swallowing Weakness or paralysis on one or both sides of the body Altered mental status or confusion Eye movement abnormalities Difficulty maintaining balance or coordination In severe cases, coma or locked-in syndrome
Diagnostic & Treatment
Diagnosis Path: Diagnosing CPM involves a combination of clinical evaluation and neuroimaging. Healthcare providers may perform the following assessments: - **Neurological Examination:** To evaluate motor skills, reflexes, and mental status. - **Magnetic Resonance Imaging (MRI):** The primary tool for confirming CPM. MRI scans typically show characteristic lesions in the central pons. - **Blood Tests:** To assess electrolyte levels, especially sodium, and other relevant markers. - **History and Physical Examination:** To identify recent medical procedures or conditions that could have contributed.
Treatment Protocols: There is no specific cure for central pontine myelinolysis. Treatment aims to manage symptoms and prevent further neurological damage: - **Supportive Care:** Including nutritional support and physical therapy. - **Electrolyte Management:** Careful correction of sodium and other imbalances under medical supervision. - **Medications:** To control muscle spasticity, seizures, or other associated symptoms. - **Monitoring:** Regular neurological assessments and imaging to track disease progression. Early recognition and cautious correction of electrolyte imbalance are crucial in preventing CPM. Once established, the extent of neurological impairment depends on the severity and rapidity of onset, as well as the promptness of medical intervention.
Clinical Advice & FAQs
Billing Guidance
Is G37.2 a billable ICD-10 code?
Yes, G37.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G37.2?
Clinical documentation must specify the nature of Central pontine myelinolysis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference